Narrative review / 2022
A scoping review identified 106 risk-benefit assessments evaluating the health effects of fish and seafood consumption.
A scoping review was conducted to evaluate existing risk-benefit assessments (RBAs) of fish, shellfish, and other seafood published between 2000 and April 2019. Across 106 identified RBAs worldwide, studies exhibited substantial heterogeneity in seafood types, compounds assessed, and methodologies. Findings generally supported recommending a variety of lean and fatty seafood for the overall population, while advising children and women of childbearing age to limit types with a high likelihood of contamination.
- Study type
- Scoping review of risk-benefit assessments
- Who was studied
- 106 risk-benefit assessment studies published from 2000 to April 2019
- What was measured
- Methodologies, nutrient benefits, and contaminant risks of seafood consumption
THE PAPER
Human health risk-benefit assessment of fish and other seafood: a scoping review.
Thomsen ST, Assunção R, Afonso C, Boué G, Cardoso C, Cubadda F, Garre A, Kruisselbrink JW, Mantovani A, Pitter JG, Poulsen M, Verhagen H, Ververis E, Voet HV, Watzl B, Pires SM. Crit Rev Food Sci Nutr, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.